Boston Scientific Q2 Adjusted EPS USD 0.86 Vs. IBES Estimate USD 0.83
BSX•Second-quarter results and full-year outlook
Jul 29 (Reuters) - Boston Scientific Q2 net income USD 905 million.
- Q2 revenue USD 5,442 million vs. IBES estimate USD 5,361 million
- Q2 EPS USD 0.61
- outlook FY organic revenue growth 5-6%
- outlook FY revenue growth 5.5-6.5%
- outlook FY adjusted EPS USD 3.28-3.32 vs. IBES estimate USD 3.36




